MedTrace Logo

C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) Exacerbation

NCT01151735 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2012-11-30

No results posted yet for this study

Summary

The study hypothesis is that treatment of Hereditary Angioedema at the time of prodromal symptoms will decrease morbidity associated with the disease

Conditions

Interventions

DRUG

C-1-esterase

1000 units of C-1-esterase inhibitor

DRUG

C-1-esterase

1500 units of C-1-esterase inhibitor

DRUG

placebo

placebo

Sponsors & Collaborators

  • Penn State University

    lead OTHER

Principal Investigators

  • Michael Lunn, DO · Penn State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-07-31
Completion
2012-07-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01151735 on ClinicalTrials.gov